These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

786 related articles for article (PubMed ID: 29316825)

  • 1. On surmounting the barriers to HPV vaccination: we can do better.
    Attia AC; Wolf J; Núñez AE
    Ann Med; 2018 May; 50(3):209-225. PubMed ID: 29316825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implementation of a human papillomavirus vaccination demonstration project in Malawi: successes and challenges.
    Msyamboza KP; Mwagomba BM; Valle M; Chiumia H; Phiri T
    BMC Public Health; 2017 Jun; 17(1):599. PubMed ID: 28651574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A model of health care provider decision making about HPV vaccination in adolescent males.
    Alexander AB; Best C; Stupiansky N; Zimet GD
    Vaccine; 2015 Aug; 33(33):4081-6. PubMed ID: 26143612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Providers' beliefs about the effectiveness of the HPV vaccine in preventing cancer and their recommended age groups for vaccination: Findings from a provider survey, 2012.
    Berkowitz Z; Malone M; Rodriguez J; Saraiya M
    Prev Med; 2015 Dec; 81():405-11. PubMed ID: 26598805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Society of behavioral medicine supports increasing HPV vaccination uptake: an urgent opportunity for cancer prevention.
    Peterson CE; Dykens JA; Brewer NT; Buscemi J; Watson K; Comer-Hagans D; Ramamonjiarivelo Z; Fitzgibbon M
    Transl Behav Med; 2016 Dec; 6(4):672-675. PubMed ID: 27718061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HPV vaccine and males: issues and challenges.
    Zimet GD; Rosenthal SL
    Gynecol Oncol; 2010 May; 117(2 Suppl):S26-31. PubMed ID: 20129653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Longitudinal Incidence of Human Papillomavirus Vaccination in Spanish Primary Care in the First 10 Years After Approval.
    Martín-Merino E; Llorente-García A; Castillo Cano B; Montero Corominas D; Huerta-Álvarez C
    Pharmaceut Med; 2019 Dec; 33(6):519-530. PubMed ID: 31933243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Programmatic issues in the implementation of an HPV vaccination program to prevent cervical cancer.
    Ault K; Reisinger K
    Int J Infect Dis; 2007 Nov; 11 Suppl 2():S26-8. PubMed ID: 18162242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Barriers and facilitators to HPV vaccination of young women in high-income countries: a qualitative systematic review and evidence synthesis.
    Ferrer HB; Trotter C; Hickman M; Audrey S
    BMC Public Health; 2014 Jul; 14():700. PubMed ID: 25004868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improving adolescent health: focus on HPV vaccine acceptance.
    Zimet GD
    J Adolesc Health; 2005 Dec; 37(6 Suppl):S17-23. PubMed ID: 16310137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Moving forward: human papillomavirus vaccination and the prevention of cervical cancer.
    Vetter KM; Geller SE
    J Womens Health (Larchmt); 2007 Nov; 16(9):1258-68. PubMed ID: 18001182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parental knowledge gaps and barriers for children receiving human papillomavirus vaccine in the Rio Grande Valley of Texas.
    Victory M; Do TQN; Kuo YF; Rodriguez AM
    Hum Vaccin Immunother; 2019; 15(7-8):1678-1687. PubMed ID: 31170031
    [No Abstract]   [Full Text] [Related]  

  • 13. Provider perceptions of barriers and facilitators of HPV vaccination in a high-risk community.
    Javanbakht M; Stahlman S; Walker S; Gottlieb S; Markowitz L; Liddon N; Plant A; Guerry S
    Vaccine; 2012 Jun; 30(30):4511-6. PubMed ID: 22561142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stopping the HPV vaccine crisis in Japan: Quantifying the benefits and risks of HPV vaccination in quality-adjusted life-years for appropriate decision-making.
    Kitano T
    J Infect Chemother; 2020 Mar; 26(3):225-230. PubMed ID: 31607433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Indicated or elective? The association of providers' words with HPV vaccine receipt.
    Fenton AT; Eun TJ; Clark JA; Perkins RB
    Hum Vaccin Immunother; 2018; 14(10):2503-2509. PubMed ID: 29847201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human papillomavirus (HPV) vaccine coverage achievements in low and middle-income countries 2007-2016.
    Gallagher KE; Howard N; Kabakama S; Mounier-Jack S; Burchett HED; LaMontagne DS; Watson-Jones D
    Papillomavirus Res; 2017 Dec; 4():72-78. PubMed ID: 29179873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The content and context of physicians' communication with males about human papillomavirus vaccination.
    Malo TL; Ali KN; Sutton SK; Perkins RB; Giuliano AR; Vadaparampil ST
    Hum Vaccin Immunother; 2016 Jun; 12(6):1511-8. PubMed ID: 26835599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. "I think they're all basically the same": parents' perceptions of human papilloma virus (HPV) vaccine compared with other adolescent vaccines.
    Ogunbajo A; Hansen CE; North AL; Okoloko E; Niccolai LM
    Child Care Health Dev; 2016 Jul; 42(4):582-7. PubMed ID: 26990908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human Papillomavirus Vaccines: Successes and Future Challenges.
    Perez S; Zimet GD; Tatar O; Stupiansky NW; Fisher WA; Rosberger Z
    Drugs; 2018 Sep; 78(14):1385-1396. PubMed ID: 30269207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human papillomavirus vaccination of males: attitudes and perceptions of physicians who vaccinate females.
    Weiss TW; Zimet GD; Rosenthal SL; Brenneman SK; Klein JD
    J Adolesc Health; 2010 Jul; 47(1):3-11. PubMed ID: 20547286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.